Hypogonadism Completed Phase 3 Trials for Testosterone enanthate (DB13944)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02159469Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With HypogonadismTreatment
NCT02504541Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)Treatment